| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Wednesday - Sep 27, 2023 |
|||||||||
| Q4 FY23 | -$1.07 | -$1.18 | $4.01B | $3.91B |
NASDAQ |
||||
|
Concentrix
CNXC
|
Q3 FY23 | $2.71 | $2.76 | $1.63B | $2.20B |
NASDAQ |
|||
|
Jefferies Financial Group
JEF
|
- | $0.32 | $0.34 | $1.28B | $1.31B |
NYSE |
|||
| Q1 FY24 | $1.14 | $1.12 | $1.29B | $1.28B |
NASDAQ |
||||
|
Worthington Industries
WOR
|
- | $2.06 | $2.04 | $1.19B | $1.23B |
NYSE |
|||
|
H.B. Fuller
FUL
|
- | $1.06 | $1.17 | $900.63M | $954.04M |
NYSE |
|||
|
The Duckhorn Portfolio
NAPA
|
Q4 FY23 | $0.15 | $0.13 | $100.10M | $99.86M |
NYSE |
|||
|
Aytu BioPharma
AYTU
|
Q4 FY23 | $0.16 | -$0.95 | $30.73M | $27.69M |
NASDAQ |
|||
|
Trio-Tech International
TRT
|
- | $0.04 | - | $9.08M | - |
AMEX |
|||
|
iBio
IBIO
|
- | $0.26 | -$0.41 | - | $200K |
NASDAQ |
|||
